140 related articles for article (PubMed ID: 37816174)
21. PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia.
Parker VL; Winter MC; Tidy JA; Palmer JE; Sarwar N; Singh K; Aguiar X; Hancock BW; Pacey AA; Seckl MJ; Harrison RF
Gynecol Oncol; 2024 Jan; 180():152-159. PubMed ID: 38091775
[TBL] [Abstract][Full Text] [Related]
22. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
[TBL] [Abstract][Full Text] [Related]
23. Experience of women on the Irish National Gestational Trophoblastic Disease Registry.
Joyce CM; Coulter J; Kenneally C; McCarthy TV; O'Donoghue K
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():206-212. PubMed ID: 35367922
[TBL] [Abstract][Full Text] [Related]
24. Current chemotherapeutic options for the treatment of gestational trophoblastic disease.
Braga A; Paiva G; Cattai CJ; Elias KM; Horowitz NS; Berkowitz RS
Expert Opin Pharmacother; 2023 Feb; 24(2):245-258. PubMed ID: 36399723
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms.
Xu D; Feng F; Pei Y; Zhang Y; Wu Y; Guo Y; Cui W
Am J Reprod Immunol; 2020 May; 83(5):e13233. PubMed ID: 32187420
[TBL] [Abstract][Full Text] [Related]
26. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN).
Cho HW; Ouh YT; Min KJ; Lee NW; Lee S; Song JY; Hong JH; Lee JK
Gynecol Oncol; 2020 Mar; 156(3):606-610. PubMed ID: 31954533
[TBL] [Abstract][Full Text] [Related]
27. Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017.
Kong Y; Zong L; Cheng H; Jiang F; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
Cancer Med; 2020 Apr; 9(7):2590-2599. PubMed ID: 32022487
[TBL] [Abstract][Full Text] [Related]
28. Surgery including fertility-sparing treatment of GTD.
Ngu SF; Ngan HYS
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():97-108. PubMed ID: 33127305
[TBL] [Abstract][Full Text] [Related]
29. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
Dantas PRS; Maestá I; Filho JR; Junior JA; Elias KM; Howoritz N; Braga A; Berkowitz RS
Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
[TBL] [Abstract][Full Text] [Related]
30. Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America.
Maestá I; de Freitas Segalla Moreira M; Rezende-Filho J; Bianconi MI; Jankilevich G; Otero S; Correa Ramirez LA; Sun SY; Elias K; Horowitz N; Braga A; Berkowitz R
Int J Gynecol Cancer; 2020 Sep; 30(9):1366-1371. PubMed ID: 32376739
[TBL] [Abstract][Full Text] [Related]
31. Management and Outcomes of Patients with Stage I and IlIl Low-Risk Gestational Trophoblastic Neoplasia Treated in Sheffield, UK, from 1997-2006.
Macdonald MC; Hancock BW; Winter MC; Coleman RE; Tidy JA
J Reprod Med; 2016 Aug; 61(7-8):341-346. PubMed ID: 30408379
[TBL] [Abstract][Full Text] [Related]
32. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
[TBL] [Abstract][Full Text] [Related]
33. Cervical gestational trophoblastic neoplasia: A rare form of gestational trophoblastic disease.
Jaiswar SP; Agrawal M; Deo S; Saad S
J Cancer Res Ther; 2022; 18(3):827-830. PubMed ID: 35900567
[TBL] [Abstract][Full Text] [Related]
34. The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian women.
Braga A; Lopes R; Campos V; Freitas F; Maestá I; Sun SY; Pedrotti LG; Bessel M; de Sousa CB; Leal E; Yela D; Uberti E; Madi JM; Viggiano M; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
Gynecol Oncol; 2023 Sep; 176():130-138. PubMed ID: 37524011
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Oral Vitamin A in Reducing β-hCG Levels in Low-Risk Gestational Trophoblastic Neoplasia Patients.
Hidayat YM; Darmadi A E; Rachmayati S; Kusumah WP; Djuwantono T; Pramatirta AY; Suardi D
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3325-3329. PubMed ID: 33247691
[TBL] [Abstract][Full Text] [Related]
36. Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia.
Rattanaburi A; Boonyapipat S; Supasinth Y
Asian Pac J Cancer Prev; 2015; 16(12):5037-41. PubMed ID: 26163637
[TBL] [Abstract][Full Text] [Related]
37. Gestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre.
Fehlmann A; Benkortbi K; Rosseel G; Meyer-Hamme U; Tille JC; Sloan-Bena F; Paoloni-Giacobino A; Rougemont AL; Bodmer A; Botsikas D; Mathevet P; Petignat P; Undurraga Malinverno M
Swiss Med Wkly; 2021 Feb; 151():w20406. PubMed ID: 33578430
[TBL] [Abstract][Full Text] [Related]
38. Gestational trophoblastic neoplasia in adolescents.
Rauh-Hain JA; Growdon WB; Braga A; Goldstein DP; Berkowitz RS
J Reprod Med; 2012; 57(5-6):237-42. PubMed ID: 22696819
[TBL] [Abstract][Full Text] [Related]
39. [Preliminary study of PD-1 inhibitor in the treatment of drug-resistant recurrent gestational trophoblastic neoplasia].
Cheng HY; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):390-394. PubMed ID: 32842245
[No Abstract] [Full Text] [Related]
40. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Abu-Rustum NR; Yashar CM; Bean S; Bradley K; Campos SM; Chon HS; Chu C; Cohn D; Crispens MA; Damast S; Dorigo O; Eifel PJ; Fisher CM; Frederick P; Gaffney DK; Han E; Huh WK; Lurain JR; Mariani A; Mutch D; Nagel C; Nekhlyudov L; Fader AN; Remmenga SW; Reynolds RK; Sisodia R; Tillmanns T; Ueda S; Wyse E; McMillian NR; Scavone J
J Natl Compr Canc Netw; 2019 Nov; 17(11):1374-1391. PubMed ID: 31693991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
